Diabetic retinopathy. Diabetes mellitus due to underlying condition with unspecified diabetic retinopathy
Conditions
Interventions
Intervention 1: Intervention group: In the first stage of the researcher's face-to-face meeting with the patient, the researcher completes the demographic information questionnaire, quality of life qu
Sponsors
Mashhad University of Medical Sciences
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Diagnosis of diabetic retinopathy by a doctor Diagnosis of a candidate for Avastin by a doctor Having a smart phone Having enough hearing Having a minimum literacy Lack of other eye diseases No history of psychological illness Satisfaction for participation
Exclusion criteria
Exclusion criteria: Having previous experience of injecting Avastin
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Anxiety score in Spielberger overt and covert anxiety questionnaire. Timepoint: Anxiety will be measured before the intervention ,before the first injection , before the second injection and after the intervention. Method of measurement: Spielberger overt and covert anxiety questionnaire.;Quality of life measuring with SF36 quality of life questionnaire. Timepoint: before the intervention and two months after the quality of life of patients will be measured. Method of measurement: Sf 36 questionnaire will be used to measure the quality of life of patients. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactNahid Aghebati
Mashhad University of Medical Sciences
Outcome results
None listed